According to The Human Protein Atlas (https://www.proteinatlas.org/) [114], a greater expression of CX3CL1 is associated with a worse prognosis in pancreatic cancer, which is consistent with the aforementioned results of Xu et al. [112], which indicates that CX3CL1 plays an important role in the development of this particular cancer (Table 2). This evidence concerns the gene CX3CL1 and familial pancreatic carcinoma.